HOMEwww.epgonline.orgDRUGSwww.epgonline.orgDISEASE KNOWLEDGEwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgREGISTERwww.epgonline.orgSEARCH
Members
Why a doctor should
Username/Email

Password ()




EPG on Twitter EPG Online Twitter
EPG Online Blog EPG Online Blog
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Search
Languages

Anti-D Immunoglobulin overview
Rh (D) incompatibility.
banner_pass = 1

Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: English
 
 
Related DrugsDrug Details
Anti-D Immunoglobulin
Drug Class Description :

Anti-D immunoglobulins.

Generic Name :

Generic

Drug description :

BPL: Solution in vials. Hyland Immuno: Solution in a pre- loaded syringe.

Presentation :

Human anti-D immunoglobulin in vials containing 250iu, 500iu, 2500iu per mL. Available from BPL. Human anti-D immunoglobulin in pre-loaded syringe 1250 i.u. per mL. Available from Hyland Immuno.

Indications :

Rh (D) incompatibility.

Adult Dosage :

0 BPL product: Antenatal prophylaxis: 500 i.u. at weeks 28 and 34. Parturition: 500iu plus 125iu for every 1ml foetal red cells in excess of 4mls by slow intramuscular injection. Sensitising events during first 20 weeks of pregnancy, 250 iu per incident by slow intramuscular injection at time of incident; injection at time of incident; after 20 weeks, 500 iu per incident by slow intramuscular injection at time of incident.

Transfusion: 125iu per ml of transfused Rh (D) incompatible transfused blood by slow 0 intramuscular injection.

Hyland Immuno product: Antenatal prophylaxis, 1250 i.u. by intramuscular injection during weeks 28 and 34. Parturition, miscarriage, abortion or other sensitising event, 1250 i.u. within 72 hours. Transplacental haemorrhage, 5, 000 i.u. or 50 i.u. per ml of foetal blood transferred. Transfusion, 50 - 100 i.u. per ml of Rh (D) incompatible transfused blood by intramuscular 0 injection.

Child Dosage :

Not applicable.

Contra Indications :

Thrombocytopenia, coagulation disorders preventing intramuscular injection.

Special Precautions :

Patients with IgA antibodies or a history of atypical reactions to blood or blood products.

Interactions :

Live vaccines.

Drug Availability :

(POM)

Drug Updated :

04 June 2009

Related Drugs - Vaccines & immunoglobulins
The prognosis of patients with diabetes is improved by interventions that reduce HbA1C Alzheimer's disease (AD) is a progressive, neurodegenerative disease which will affect most of us at one point in time, and it’s prevalence increases with age. Opioid and Pain Management - understanding, management, diagnosis and treatment information www.hae-awareness.net is a CPD-accredited interactive training programme for physicians involved in the care and treatment of patients with hereditary angioedema
New and updated Drugs
UK Drugs EPG Medical News Feed
Spanish Drugs EPG Medical News Feed
German Drugs EPG Medical News Feed
Norweigan Drugs EPG Medical News Feed
Netherlands Drugs EPG Medical News Feed
Swedish Drugs EPG Medical News Feed
French Drugs EPG French Drugs Feed
Portuguese Drugs EPG Portuguese Drugs Feed
Italian Drugs EPG Italian Drugs Feed

Atopic Dermatitis

Atopic Dermatitis

CONNECT

DISEASE CENTRES Disease Centres feed

AFFILIATE PARTNERS

QUICK SEARCH

GUIDELINES UK Drug Data Feed

DRUG DATA UK Drug Data Feed

REFERENCES